Theranos, Inc.
3200 Hillview Avenue
Palo Alto
California
94304
United States
Tel: 650-838-9292
Fax: 650-838-9165
Website: http://www.theranos.com/
Email: info@theranos.com
232 articles about Theranos, Inc.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 22, 2020.
-
The government has added additional charges of conspiracy, wire fraud, and forfeiture.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 16, 2020.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 2, 2020.
-
Things are looking a little bit rosier for Elizabeth Holmes and the criminal charges against her after a federal judge dismissed some of the charges she is facing.
-
In a filing this week, the government said that tens of thousands of patients received “unreliable blood tests,” which deprived them of money and placed their health at risk.
-
Attorneys Representing Elizabeth Holmes Claim the Theranos Founder Hasn't Paid Them in a Year
10/7/2019
On Friday, Holmes’ attorneys from the firm Cooley LLP, who are representing her in a civil lawsuit brought against Theranos and Walgreens, filed a motion with the courts to withdraw from the case over Holmes’ failure to pay them for their work. -
Today has been marked by a wide range of life science and biopharma stories. Here’s a broader look at some of the top stories.
-
Exclusive: MasterControl Software Provides Efficiency, Transparency for Life Science Companies
5/8/2019
There are several lessons that companies and investors can learn from the collapse of Theranos, and one of the key takeaways is in the area of transparency. -
In recent months, Holmes has become the subject of documentaries, books and a planned major motion picture. Now, the black turtleneck-clad entrepreneur will become the subject of a limited series on Hulu starring Kate McKinnon.
-
Theranos Whistleblower Tyler Shultz to Participate in Keynote Interview at DeviceTalks Boston
3/19/2019
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart.
-
Elizabeth Holmes, the founder of the now-failed Theranos, has become a subject of fascination for many people. Her ability to secure billions of dollars for her company without showing any supporting evidence of the product to investors is a compelling study.
-
As a student at a private school in Houston, Elizabeth Holmes had a reputation for being determined to accomplish her goals, no matter if she came in dead last. She was also notoriously private about her life.
-
Companies are filling in the gaps and the entire area of so-called “liquid biopsies” is hot these days, with companies like Guardant Health, Karius, Freenome, Apostle and GRAIL Bio entering the market. With this backdrop, let’s look at some companies working in the same field as the now-defunct T...
-
Updated: Two Theranos Documentaries Unveiled This Week as Attorneys Wrangle Over Criminal Charges
1/23/2019
A documentary about Theranos will be shown at Sundance, while ABC News will unveil its own documentary on the company this week. -
Readers' Picks: Top 10 Stories of 2018
12/28/2018
As we look back over the year, we noticed some stories just grabbed readers more than others. Here’s a look at the top 10 stories of the year, including job cuts, best-selling drugs, up-and-coming companies,scandals, clinical trials, and more. -
In writing literally hundreds of stories this year, two BioSpace writers, Alex Keown and Mark Terry, found certain stories particularly intriguing or impactful. Some of those were such big topics that they were covered over a series of stories. Looking back at 2018, here are their Top 10.
-
Theranos fit in with the opaque culture of Silicon Valley, which allowed it to thrive and amass a fortune without delivering anything, book argues.
-
Hours after it was reported that Elizabeth Holmes was shutting down Theranos for good, the company’s website has gone dark.
-
Reuters recently issued a special report focusing on National Securities Corp., alleging conflicts of interest when the company’s analysts recommend certain biotech companies.